- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04353258
Research Intervention to Support Healthy Eating and Exercise (RISE)
December 17, 2025 updated by: Tricia Leahey, University of Connecticut
Using Behavioral Economic Strategies to Address Obesity in Economically Disadvantaged Adults
The primary aim of this study is to test the efficacy of a behavioral economics intervention for weight loss in adults from economically disadvantaged backgrounds.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
195
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Connecticut
-
Hartford, Connecticut, United States, 06103
- UConn Weight Management Research Lab
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age between 18-75
- BMI between 25-55kg/m2
- All sexes
- All racial/ethnic groups
- Low SES and/or report qualifying for federal, state or local benefits
- Have a smartphone and willing to use for research purposes
Exclusion Criteria:
- <18-75>years of age
- Report being unable to walk 2 blocks without stopping
- Are currently participating in weight loss treatment, have a history of bariatric surgery, or lost ≥5% in the past 6-months
- Are pregnant or plan to become pregnant within 1 year
- Report a heart condition, chest pain during periods of rest or activity, or loss of consciousness on the Physical Activity Readiness Questionnaire
- Report a medical condition that could jeopardize their safety in a weight control program with diet and exercise guidelines
- Have diabetes and are on insulin
- Report a medical condition that could jeopardize their safety in a weight loss program with diet and exercise guidelines
- Report conditions that, in the judgment of the PI, would render them unlikely to follow the protocol (e.g., relocation, dementia, unable to read and write in English)
- Report unable to read and write English
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Behavioral Economics intervention (BE mHealth)
Participants will receive a 12-month behavioral weight loss intervention delivered primarily via mobile phone (mHealth) that includes behavioral economics components.
|
Participants will receive a 12-month behavioral weight loss intervention delivered primarily via mobile phone (mHealth) that includes behavioral economics components.
|
|
Active Comparator: Standard mHealth intervention (mHealth)
Participants will receive a 12-month behavioral weight loss intervention delivered primarily via mobile phone (mHealth).
|
Participants will receive a 12-month behavioral weight loss intervention delivered primarily via mobile phone (mHealth).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weight
Time Frame: Baseline, 2 month, 6 month, 12 month, 18 months
|
Weight change measured on a digital scale to the nearest 0.1-kilogram
|
Baseline, 2 month, 6 month, 12 month, 18 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Tricia Leahey, PhD, University of Connecticut
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 7, 2021
Primary Completion (Actual)
December 17, 2024
Study Completion (Actual)
December 17, 2024
Study Registration Dates
First Submitted
April 16, 2020
First Submitted That Met QC Criteria
April 16, 2020
First Posted (Actual)
April 20, 2020
Study Record Updates
Last Update Posted (Actual)
January 9, 2026
Last Update Submitted That Met QC Criteria
December 17, 2025
Last Verified
July 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H19-141
- 1R01DK118957 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on Behavioral Economics intervention (BE mHealth)
-
University of PennsylvaniaNational Institutes of Health (NIH); Geisinger Clinic; Harvard Vanguard Medical...CompletedCardiovascular Disease (CVD)United States
-
Vanessa OlbrechtTerminated
-
Fatima Jinnah Women UniversityNot yet recruitingType 2 Diabetes Risk Reduction in Young AdultsPakistan
-
Baylor College of MedicineTerminated
-
Saglik Bilimleri UniversitesiRecruitingSmoking Behaviors | Physical InactivityTurkey
-
Kaiser PermanenteActive, not recruiting
-
University of CadizAndalusian Health ServiceRecruiting
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI); Ohio UniversityRecruitingMelanoma | Breast Cancer | Multiple Myeloma | Lung Cancer | Prostate CancerUnited States
-
Children's National Research InstituteRecruitingSexually Transmitted DiseasesUnited States
-
Kaiser PermanenteCompletedSmoking | Smoking CessationUnited States